Public Statement
Antitrust Issues in Settlement of Pharmaceutical Patent Disputes
Date
1. Introduction I want to thank the Healthcare Antitrust Forum for the invitation to talk about some recent developments in healthcare antitrust at the FTC. (1) An agency representative's usual...